James D Davis, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 11900 Grant St Ste 220, Northglenn, CO 80233 Phone: 303-673-1420 Fax: 303-452-4398 |
Michael B. Stern, D.p.m., P.c. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 10465 Melody Dr, Suite 313, Northglenn, CO 80234 Phone: 303-451-5900 Fax: 303-451-1233 |
Colorado Clinics For Foot And Ankle Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 11310 N Huron Street, Suite 20, Northglenn, CO 80234 Phone: 303-577-0110 Fax: 303-577-0112 |
Dr. Daniel Lee Shadrick, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 11900 Grant St Ste 220, Northglenn, CO 80233 Phone: 303-673-1420 Fax: 303-452-4398 |
Dr. Michael Barry Stern, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 10465 Melody Dr, Suite 313, Northglenn, CO 80234 Phone: 303-451-5900 Fax: 303-451-1233 |
News Archive
New data about amyloid precursor protein, or APP, a protein implicated in development of Alzheimer's disease, suggests it also may have a positive role - directly affecting learning and memory during brain development. So is APP good or bad? Researchers at Georgetown University Medical Center say both, and that a balance of APP is critical.
Questions have been raised by many health experts on whether being infected with SARS-CoV-2 brings lasting immunity. Now, scientists have uncovered signs of strong and lasting immunity in people who even had a mild illness of COVID-19.
Mobile Health Expo, the only event focusing on the convergence of mobile technology and healthcare across the entire mobile health ecosystem, today revealed some highlights from the conference program that focuses on the truly international nature of mobile health. Speakers representing both developing and developed nations will share case studies and best practices of how mobile health is being used in other countries.
The news about antidepressant medications over the past several years has been mixed. The bad news from large multicenter studies such as STAR*D is that current antidepressant medications are effective, but not as effective as one might hope. Thus, there is a significant need for new treatment mechanisms for depression. On that front, there has been mixed news as well.
Celera Corporation today reported net revenues of $31.4 million for the first quarter of 2010 that ended March 27, 2010, compared to $45.7 million in the prior year quarter. For the first quarter of 2010, Celera reported a net loss $12.5 million, or $0.15 per share, compared to a net loss of $1.4 million, or $0.02 per share, for the prior year quarter.
› Verified 4 days ago